Form 4 for COGT Cogent Biosciences, Inc.
Accepted 2023-06-13 00:00:00 ET · period of report 2023-06-09 · accession 0001104659-23-070794 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-06-13 | 2023-06-09 | COGT | Fairmount Funds Management LLC | 10%, See Remarks | P - Purchase | $12.00 | +800.0K | 3.27M | +32% | +$9.60M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-09 | P | A | 800,000 | $12.00 | 3,272,124 | I Fairmount Healthcare Fund II LP | — | — | (F2) Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series A Preferred Stock held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein. |